Volume 18
Number 5
Dec 2014
Back to issue
C.A. den Uil, J.M. Cheng, L.S.D. Jewbali, K. Nieman, K.M. Akkerhuis, E.A. Dubois, F. Zijlstra

In recent years, three randomised controlled trials questioned the use of the intra-aortic balloon pump (IABP) in populations of high-risk PCI (BCIS-1), acute myocardial infarction (CRISP-AMI), and cardiogenic shock (IABP-SHOCK II). This review describes these and other IABP trials, as well as their outcome on mortality. Clinical implications are addressed. There is a pressing need for adequately powered randomised controlled trials testing the optimal timing of mechanical circulatory support as well as device design in cardiogenic shock.

Back to issue - Download PDF